The Korean Journal of Nuclear Medicine (대한핵의학회지)

The Korean Society of Nuclear Medicine (대한핵의학회)
권호 표지

Dopamine Transporter Density of the Basal Ganglia in Children with Attention Deficit Hyperactivity Disorder Assessed with I-123 IPT PECT

I-123 IPT SPECT를 이용한 주의력결핍 과잉행동장애 아동에서의 methylphenidate 투여 전후의 기저 신경절 도파민 운반체 밀도 변화 측정

  • Ryu, Won-Gee (Department of Diagnostic Radiology, College of Medicine, Yonsei University) ;
  • Kim, Tae-Hoon (Department of Diagnostic Radiology, College of Medicine, Yonsei University) ;
  • Ryu, Young-Hoon (Department of Diagnostic Radiology, College of Medicine, Yonsei University) ;
  • Yun, Mi-Jin (Department of Diagnostic Radiology, College of Medicine, Yonsei University) ;
  • Cheon, Keun-Ah (Department of Psychiatry, College of Medicine, Yonsei University) ;
  • Chi, Dae-Yoon (Department of Chemistry, Inha University) ;
  • Kim, Jong-Ho (Department of Nuclear Medicine, Gachon Medical School) ;
  • Choi, Tae-Hyun (Department of Nuclear Medicine, Gachon Medical School) ;
  • Lee, Jong-Doo (Department of Diagnostic Radiology, College of Medicine, Yonsei University)
  • 류원기 (연세대학교 의과대학 진단방사선과학 교실) ;
  • 김태훈 (연세대학교 의과대학 진단방사선과학 교실) ;
  • 유영훈 (연세대학교 의과대학 진단방사선과학 교실) ;
  • 윤미진 (연세대학교 의과대학 진단방사선과학 교실) ;
  • 천근아 (연세대학교 의과대학 정신과학 교실) ;
  • 지대윤 (인하대학교 화학과) ;
  • 김종호 (가천대학교 의과대학 핵의학과 교실) ;
  • 최태현 (가천대학교 의과대학 핵의학과 교실) ;
  • 이종두 (연세대학교 의과대학 진단방사선과학 교실)
  • Published : 2003.08.30
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: Attention deficit hyperactivity disorder (ADHD) has been known as psychiatric disorder in childhood associated with dopamine dysregulation. In present study, we investigated changes in dopamine transporter (DAT) density of the basal ganglias using I-123 N-(3-iodopropen-2-yl) -2-carbomethoxy-3beta-(4-chlorophenyl) tropane [I-123 IPT] SPECT in children with ADHD before and after methylphenidate treatment. Materials and Method: Nine drug-naive children with ADHD and seven normal children were included in the study. We peformed brain SPECT two hours after the intravenous administration of I-123 IPT and made both quantitative and qualitative analyses using the obtained SPECT data, which were reconstructed for the assessment of soecific/nonspecific DAT binding ratios in the basal ganglia. All children with ADHD reperformed [123I]IPT SPECT after treatment with methylphenidate(0.7mg/kg/d) during about 8 weeks. SPECT data reconstructed for the assessment of specific/nonspecific DAT binding ratio of the basal ganglia were compared between before and after treatment methylphenidate. We investigated correlation between the change of ADHD symptom severity assessed with ADHD rating scale-IV and specific/nonspecific DAT binding ratio of basal ganglia. Results: Children with ADHD had a significantly greater specificinonspecific DAT binding ratio of the basal ganglia comparing to normal children(Right : z = 2.057, p = 0.041 : Left : z : 2.096, p = 0.032). Under treatment with methylphenidate in all children with ADHD, specificinonspecific DAT binding ratio of both basal ganglia decreased significantly greater than before treatment with methylphenidate (Right : t = 3.239, p = 0.018 ; Left : t = 3.133, p = 0.020). However, no significant correlation between the change of ADHD symptom severity scores and specific/nonspecific DAT binding ratio of the basal ganglia were found. Conclusions: These findings support the complex dysregulation of the dopaminergic neurotransmitter system in children with ADHD.

목적: 주의력결핍 과잉행동장애 (Attention Deficit Hyperactivity disorder : 이하 ADHD)는 도파민계의 이상 기능으로 생기는 대표적 소아정신과 질환이다. Methylphenidate는 dopamine transporter(DAT)를 차단함으로써 ADHD 증상을 호전시키는 약물로 널리 알려져 있다. 따라서 본 연구에서는 ADHD 아동들을 대상으로 I-123 IPT SPECT를 이용하여 methylphenidate 투여 전후의 DAT density 양상을 비교해 보고자 한다. 대상 및 방법: 연구대상은 9명의 ADHD 아동과 7명의 정상 대조군이었다. ADHD 아동군과 정상 대조군에게 모두 약물 비노출 상태에서 $[^{123}I]IPT$를 정맥 주사후 2시간이 경과한 상태에서 SPECT를 촬영하였다. 이후 ADHD 아동군을 대상으로 methylphenidate 0.7mg/kg/d을 투여한 후 약 8주가 경과한 상태에서 $[^{123}I]IPT$ SPECT를 재촬영 하였다. Methylphenidate 투여 전과 후의 좌, 우측 기저 신경절 DAT 특이결합/비특이결합 비율을 구한 뒤 비교하였고, 약물 투여 후의 ADHD 증상 척도로 측정한 증상 호전도와 좌, 우측 기저 신경절 DAT 특이결합/비특이결합 비율 변화사이의 상관관계를 알아보았다. 결과: ADHD 아동군에서 약물 비노출 상태와 정상 대조군 사이의 좌, 우측 기저 신경절 DAT특이결합/비특이결합 비율을 비교한 결과 DAT 결합 비율이 정상 대조군에 비해서 유의하게 증가되었다. (Right : z=2.057, p=0.041 ; Left z=2.096, p=0.032). 또한 ADHD 아동들에게 methylphenidate 투여 전과 후 상태에서의 기저 신경절 DAT 특이결합/비특이결합 비율을 비교한 결과, methylphenidate 투여 후 상태가 methylphenidate 투여 전 상태에 비해 좌, 우측 DAT 결합비율이 유의하게 낮아진 것을 관찰할 수 있었다. (우측 : t=3.239, p=0.018 ; 좌측 : t=3.133, p=0.020). ADHD 증상의 호전도와 좌, 우측 기저 신경절 DAT 특이결합/비특이결합 비율 변하사이에는 유의한 상관관계를 보이지 않았다. 결론: 이러한 결과는 주의력결핍 과잉행동장애의 치료제인 methylphenidate가 작용하는 기전을 이용하여 주의력결핍 과잉행동장애의 병태생리와 연관된 도파민계 기능이상 가능성을 지지한다고 생각된다.

Keywords

References

  1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental disorder, 4th Edition. APA press, Washington, D.C. 1994
  2. Tayler E. The epidmiology of childhood hyperactivity. Oxford：Oxford University Press,1991
  3. Jensen PS, Mrazek D, Knapp P. Evolution and revolution in child psychiatry：ADHD as a disorder of adaptation. J Am Acad Child Adolesc Psychiatry 1997；36：1672~9
  4. Biederman J, Farone S, Keenan K, Knee D, Tsuang M. Family－genetic and psychosocial isk factors in DSM－III attention deficit disorder. J Am Acad Child Adolesc Psychiatry 1990；29：526－33
  5. Biederman J, Newcorn J, Sprich S. Co－morbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am J Psychiatry 1991；148：564－77
  6. Goodman R, Stevenson J. A twin study of hyperactivity：II. The aetiological role of genes, family relationships, and perinatal adversity. J Child Psychol Psychiatry 1989；30：691－709
  7. Cook EH Jr, Stein MA, Krasowski MD, Cox NJ, Olkon DM, Kieffer JE et al. Association of attention －deficit disorder and the dopamine transporter gene. Am J Hum Genet 1995；56：993－8
  8. Gill M, Daly G, Heron S, Hawi Z, Fitzgerald M. Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism. Mol Psychiatry 1997；2：311－3
  9. Greenhill LL. Pharmacologic treatment of attention deficit hyperactivity disorder. Psychiatr Clin North Am 1992；15：1－27
  10. Rapport M, Denney C, DuPaul G, Gardner M. Attention deficit disorder and methylphenidate： normalization rates, clinical effectiveness, and response prediction in 76 children. J Am Acad Child Adolesc Psychiatry 1994；33：882－93
  11. Rapport M, Denney C, DuPaul G, Gardner M. Attention deficit disorder and methylphenidate： normalization rates, clinical effectiveness, and response prediction in 76 children. J Am Acad Child Adolesc Psychiatry 1994；33：882－93
  12. Zametkin AJ, Liebenauer LL, Fitzgerald GA, King AC, Minkunas DV, Herscovitch P, et al. Brain metabolism in teenagers with attention－deficit hyperactivity disorder. Arch Gen Psychiatry 1993；50：333－40
  13. Amen DG, Carmichael BD. High－resolution brain SPECT imaging in ADHD. Ann Clin Psychiatry 1997；9：81－6
  14. Sieg KG, Gaffney GR, Preston DF, Hellings JA. SPECT brain imaging abnormalities in attention deficit hyperactivity disorder. Clin Nucl Med 1995；20：55－60
  15. Ernst M, Zametkin AJ, Matochik JA, Pascualvaca D, Jons PH, Cohen RM. High midbrain [$^18$F]DOPA accumulation in children with attention deficit hyperactivity disorder. Am J Psychiatry 1999；156：1209－15
  16. Dresel S, Krause J, Krause K－H, LaFougere C, Brinkbaumer K, Kung HF, et al. Attention deficit hyperactivity disorder：binding of [$^99$mTc]TRODAT －1 to the dopamine transporter before and after methylphenidate treatment. Eur J Nucl Med 2000；27：1518－24
  17. Dougherty DD, Bonab AA, Spencer TJ, Rauch SL, Madras BK, Fischman AJ. Dopamine transporter density in patients with attention deficit hyperactivity disorder. Lancet 1999；354：2132－3
  18. van Dyck CH, Quinlan DM, Cretella LM, Staley JK, Malison RT, Baldwin RM, et al. Unaltered Dopamine Transporter Availability in Adult Attention Deficit Hyperactivity Disorder. Am J Psychiatry 2002；159：309－12
  19. Cheon KA, Ryu YH, Namkoong K, Kim CH, Lee JD. Dopamine transporter density of the basal ganglia assessed with [$^123$I]IPT SPECT before and after methylphenidate treatment in Children with Attention Deficit Hyperactivity Disorder. Korean J psychopharmacol 2002；13(2)：1－9
  20. Chang LT. A method for attenuation correction in ratio nuclide computed tomography. IEEE Trans Nucl Sci 1978：25；638－43
  21. Swanson J, Castellanos FX, Murias M, LaHoste G, Kennedy J. Cognitive neuroscience of attention deficit hyperactivity disorder and hyperkinetic disorder. Curr Opin Neurobiol 1998；8：263－71
  22. Lou HC, Henriksen L, Bruhn P, Borner H, Bieber Nielsen J. Striatal dysfunction in attention deficit and hyperkinetic disorder. Arch Neurol 1989；46：48－52
  23. Vaidya CJ, Austin G, Kirkorian G, Ridlehuber HW, Desmond JE, Glover GH, et al. Selective effects of methylphenidate in attention deficit hyperactivity disorder：a functional magnetic resonance study. Proc Natl Acad Sci U S A 1998；95：14494－9